. 2017 Jun 2;12(6):e0178371. doi: 10.1371/journal.pone.0178371

Table 1. Demographic and clinical data of cohort.

Group	Sex		Age^† (y)	Disease Duration at MRI^† (mo)	ALSFRS-R^†	ALSFRS-R_3M^†	R_DP^†
Group	F	M	Age^† (y)	Disease Duration at MRI^† (mo)	ALSFRS-R^†	ALSFRS-R_3M^†	R_DP^†
ALS	10	17	58.1±12.3	16.1±12.7	38.8±8.7	36.3±8.8	0.8±1.1
ALS bulbar	8	8	59.8±11.8	16.6±13.9	35.9±10.0	33.1±9.8	1.1±1.4
ALS limb	2	9	55.6±13.2	15.3±11.3	43.0±3.5	41.1±4.3	0.8±0.4
Controls	12	23	57.7±13.0	-	-	-	-

^† Data are means ± standard deviation,

ALS = amyotrophic lateral sclerosis, F = female, M = male, y = years, mo = months, ALSFRS-R = revised ALS functional rating scale, ALSFRS-R_3M = ALSFRS-R 3 months follow-up, R_DP = disease progression rate